US Patent Issued to Syndax Pharmaceuticals on March 3 for "Combinations of menin inhibitors and CYP3A4 inhibitors and methods of use thereof" (Massachusetts, Pennsylvania, California Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,590, issued on March 3, was assigned to Syndax Pharmaceuticals Inc. (New York).

"Combinations of menin inhibitors and CYP3A4 inhibitors and methods of use thereof" was invented by Gerard M. McGeehan (Newtown Square, Pa.), Peter Ordentlich (Lexington, Mass.), Galit Rosen (Newton, Mass.) and Steven A. Smith (San Jose, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to combinations of menin inhibitors with one or more CYP3A4 inhibitors, pharmaceutical compositions thereof, and methods of treating cancer and other diseases mediated by the menin-HLL interaction. Accordingly, the present disclosure provides compound...